AR003446A1 - Peptidos derivados de la proteina 60 humana por shock termico para diagnosis y tratamiento de diabetes, las composiciones farmaceuticas y los metodos para diagnosticar - Google Patents

Peptidos derivados de la proteina 60 humana por shock termico para diagnosis y tratamiento de diabetes, las composiciones farmaceuticas y los metodos para diagnosticar

Info

Publication number
AR003446A1
AR003446A1 ARP960103410A AR10341096A AR003446A1 AR 003446 A1 AR003446 A1 AR 003446A1 AR P960103410 A ARP960103410 A AR P960103410A AR 10341096 A AR10341096 A AR 10341096A AR 003446 A1 AR003446 A1 AR 003446A1
Authority
AR
Argentina
Prior art keywords
diagnosis
treatment
diagnosing
pharmaceutical compositions
diabetes
Prior art date
Application number
ARP960103410A
Other languages
English (en)
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of AR003446A1 publication Critical patent/AR003446A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/80—Fluorescent dyes, e.g. rhodamine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Un péptido derivado de la proteína 60 humana por shock térmico para el diagnóstico y tratamiento de diabetes caracterizado porque está seleccionadode los siguientes péptidos identificados y sus sales y derivados funcionales. Pueden utilizarsepéptidos nuevos que son epítopes de la proteína por choquetérmico 60 KDa (hsp 60) para el diagnóstico y tratamiento de la diabetes mellitus insulina-dependiente (DMID) que contiene a estos péptidos y tambiénse describen los equipos parautiliz ar en el diagnóstico de DMID. Además describen métodos para diagnosticar composiciones farmacéuticas, equipos dediagnóstico y uso de dichos antígenos para la fabricación de un equipo de diagnóstico.
ARP960103410A 1995-06-30 1996-07-01 Peptidos derivados de la proteina 60 humana por shock termico para diagnosis y tratamiento de diabetes, las composiciones farmaceuticas y los metodos para diagnosticar AR003446A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL11440795A IL114407A0 (en) 1995-06-30 1995-06-30 Novel peptides and pharmaceutical compositions comprising them

Publications (1)

Publication Number Publication Date
AR003446A1 true AR003446A1 (es) 1998-08-05

Family

ID=11067704

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960103410A AR003446A1 (es) 1995-06-30 1996-07-01 Peptidos derivados de la proteina 60 humana por shock termico para diagnosis y tratamiento de diabetes, las composiciones farmaceuticas y los metodos para diagnosticar

Country Status (19)

Country Link
US (1) US6682897B1 (es)
EP (1) EP0845943B1 (es)
KR (1) KR100454554B1 (es)
CN (1) CN1102598C (es)
AR (1) AR003446A1 (es)
AT (1) ATE290315T1 (es)
AU (1) AU710882B2 (es)
CA (1) CA2225675C (es)
CZ (1) CZ295110B6 (es)
DE (1) DE69634438T2 (es)
DK (1) DK0845943T3 (es)
ES (1) ES2239770T3 (es)
HR (1) HRP960307A2 (es)
HU (1) HUP9901688A3 (es)
IL (2) IL114407A0 (es)
NO (1) NO320715B1 (es)
UY (1) UY24270A1 (es)
WO (1) WO1997001959A1 (es)
ZA (1) ZA965565B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6488933B2 (en) 1995-07-05 2002-12-03 Yeda Research And Development Co. Ltd. Preparations for the treatment of T cell mediated diseases
JP3745380B2 (ja) * 1996-05-14 2006-02-15 ヴィンアッカー，エルンスト―ルートヴィッヒ プリオンタンパク質に結合し、イソ型ＰｒＰ▲上ｃ▼とＰｒＰ▲上ｓｃ▼を識別することが可能なシャペロン
US5993803A (en) * 1996-08-30 1999-11-30 Yeda Research And Development Co., Ltd. Method of reducing the severity of host vs graft reaction by down-regulating hsp60 autoimmunity
CA2394504A1 (en) * 1999-12-15 2001-06-21 Peptor Ltd. Fragments and antagonists of heat shock protein 60
CA2420499A1 (en) * 2000-08-25 2002-02-28 Yeda Research And Development Co. Ltd. Methods of treatment or prevention of autoimmune diseases with cpg-containing polynucleotide
WO2003063759A2 (en) 2002-01-31 2003-08-07 Peptor Ltd. Hsp peptides and analogs for modulation of immune responses via antigen presenting cells
AU2003209623A1 (en) * 2002-02-19 2003-09-09 Yeda Research And Development Co. Ltd. Dual-effect ligands comprising anti-inflammatory hsp peptide epitopes for immunomodulation
ES2433915T3 (es) 2002-05-21 2013-12-13 Irun R. Cohen Vacunas de ADN que codifican proteínas de choque térmico
WO2004098489A2 (en) * 2003-05-12 2004-11-18 Peptor Ltd. Compositions and methods for modulation of specific epitopes of hsp60
WO2005048914A2 (en) * 2003-11-24 2005-06-02 Yeda Research & Development Co. Ltd. Dna vaccines encoding hsp60 peptide fragments for treating autoimmune diseases
AU2005207891B2 (en) 2004-01-28 2010-04-01 Andromeda Biotech Ltd. Hsp therapy in conjunction with a low antigenicity diet
WO2006072946A2 (en) * 2005-01-04 2006-07-13 Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science Hsp60, hsp60 peptides and t cell vaccines for immunomodulation
CU23701A1 (es) 2008-12-29 2011-09-21 Ct Ingenieria Genetica Biotech Método de tratamiento de enfermedades inflamatorias intestinales y diabetes tipo i
US9102942B2 (en) 2010-02-04 2015-08-11 EWHA University—Industry Collaboration Foundation Pharmaceutical composition for inhibiting abnormal proliferation of cells
ITCO20120007A1 (it) * 2012-02-21 2013-08-22 Nuovo Pignone Srl Dispositivo di filtraggio dell'aria in ingresso per un impianto
WO2013128453A1 (en) 2012-03-01 2013-09-06 Yeda Research And Development Co. Ltd. Regeneration of islet beta cells by hsp60 derived peptides
AU2013227249A1 (en) 2012-03-01 2014-09-11 Yeda Research And Development Co. Ltd. Hsp60 derived peptides and peptide analogs for suppression and treatment of non-autoimmune diabetes
EP3448415A4 (en) * 2016-04-29 2019-11-06 Araim Pharmaceuticals, Inc. TISSUE PROTECTIVE PEPTIDES FOR PREVENTING AND TREATING DISEASES AND DISORDERS ASSOCIATED WITH TISSUE INJURY
CN111035755B (zh) * 2020-01-08 2023-04-14 中国医学科学院医学生物学研究所 一种1型糖尿病疫苗及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242823A (en) * 1986-03-07 1993-09-07 International Genetic Engineering, Inc. Cloning of the 38kd Mycoplasma hyorhinis regression-associated antigen
US4976958A (en) * 1987-02-26 1990-12-11 Scripps Clinic And Research Foundation Mycobacterial recombinants and peptides
US5114844A (en) * 1989-03-14 1992-05-19 Yeda Research And Development Co., Ltd. Diagnosis and treatment of insulin dependent diabetes mellitus

Also Published As

Publication number Publication date
CZ295110B6 (cs) 2005-05-18
ES2239770T3 (es) 2005-10-01
NO976094D0 (no) 1997-12-29
KR19990028640A (ko) 1999-04-15
EP0845943B1 (en) 2005-03-09
AU6484596A (en) 1997-02-05
CN1193889A (zh) 1998-09-23
IL122757A0 (en) 1998-08-16
US6682897B1 (en) 2004-01-27
EP0845943A4 (en) 2002-04-10
IL122757A (en) 2001-07-24
KR100454554B1 (ko) 2005-04-06
CN1102598C (zh) 2003-03-05
MX9800191A (es) 1998-05-31
UY24270A1 (es) 2000-12-29
AU710882B2 (en) 1999-09-30
DK0845943T3 (da) 2005-07-11
WO1997001959A1 (en) 1997-01-23
EP0845943A1 (en) 1998-06-10
NO976094L (no) 1998-02-02
ZA965565B (en) 1997-02-26
HRP960307A2 (en) 1998-04-30
DE69634438T2 (de) 2006-02-09
HUP9901688A3 (en) 1999-12-28
JPH11509196A (ja) 1999-08-17
JP3955627B2 (ja) 2007-08-08
IL114407A0 (en) 1995-10-31
CZ411797A3 (cs) 1998-06-17
HUP9901688A2 (hu) 1999-09-28
DE69634438D1 (de) 2005-04-14
ATE290315T1 (de) 2005-03-15
NO320715B1 (no) 2006-01-23
CA2225675C (en) 2010-09-21
CA2225675A1 (en) 1997-01-23

Similar Documents

Publication Publication Date Title
AR003446A1 (es) Peptidos derivados de la proteina 60 humana por shock termico para diagnosis y tratamiento de diabetes, las composiciones farmaceuticas y los metodos para diagnosticar
BR9810907A (pt) Anticorpos monoclonais e policlonais, peptìdeo suscetìvel de gerar um anticorpo, agente imunogênico, sequência de nucleotìdeos, composição farmacêutica, uso de pelo menos um anticorpo, kit de diagnóstico, e, processo para preparar um agente imunogênico
ATE165395T1 (de) Inhibitoren des tumorwachstums aus geweben, methoden ihrer herstellung und verwendungen
ES2180754T3 (es) Compuestos y metodos para la deteccion de infeccion por t. cruzi.
ES2136654T3 (es) Herramientas para el diagnostico y tratamiento de la enfermedad de alzheimer.
FI912965A0 (fi) Vaccin innehaollande protein fraon klass 1-yttermembranen av meningokocker.
DK0643726T3 (da) Peptider af humant p53-protein til anvendelse i sammensætninger, som inducerer humant T-celle-respons, og humane p53-protei
Isersky et al. Immunochemical cross-reactions of human amyloid proteins with human immunoglobulin light polypeptide chains
NO965621D0 (no) Nye hIL-4-mutantproteiner som antagonister eller partielle agonister for det humane interleukin 4
DE68929545D1 (de) Pollen Allergene
AR002949A1 (es) Análogos del peptido p277 y composiciónes farmaceuticas y preparaciónes que los comprenden para el tratamiento o diagnostico de diabetes y un equipo para diagnosticar.
ATE244299T1 (de) Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis
ES2112340T3 (es) Proteinas mutantes de il-4 humana.
ATE175119T1 (de) Vakzine gegen immunodefizienz-virus der katze (kiv)
DE69634092D1 (de) Herstellung von antikörpern
MX9301675A (es) Composiciones que contienen peptidos para inducir tolerancia de las celulas t a un antigeno.
DK0954529T3 (da) Porphyromonas gingivalis-antigener til diagnose og behandling af rodbetændelse
DE69841322D1 (de) Hepatitis c rezeptorprotein cd81
ATE364701T1 (de) Immunoreaktive und immunotherapeutische moleküle welche in individuen mit insulin-abhängiger diabetes mellitus interagieren
BR9611455A (pt) Compostos e métodos para a detecção e prevenção de infecção por t. cruzi.
DE69230855D1 (de) System der bereitstellung eines impfstoffes auf peptidbasis, das sein eigenes adjuvans bildet, und seine herstellung
DE69002946D1 (de) Paracetamol enthaltende arzneizubereitung.
FI971427A0 (fi) Peptidit ja niitä sisältävät farmaseuttiset koostumukset
CO4820439A1 (es) Compuestos y metodos para la deteccion y la prevencion de la infeccion por el t. cruzi
DE59006159D1 (de) Verwendung von macrolactonen als antiallergica.

Legal Events

Date Code Title Description
FC Refusal